This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Friedrich-Alexander-Universitat Erlangen-Nürnberg. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovations of Olaf Prante
Introduction
Olaf Prante is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of neurotensin receptor-related conditions. His work has implications for various health issues, including tumors and hematological malignancies.
Latest Patents
Olaf Prante holds a patent for a compound that can be utilized in the diagnosis, treatment, or prevention of neurotensin receptor-related conditions. The patent is titled "Diagnosis, treatment and prevention of neurotensin receptor-related conditions." This invention describes a compound of formula (I) that addresses critical health challenges.
Career Highlights
Throughout his career, Olaf Prante has been associated with several prestigious institutions. He has worked at Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen. His contributions to these institutions have been instrumental in advancing research and innovation in medical science.
Collaborations
Olaf Prante has collaborated with esteemed colleagues such as Torsten Kuwert and Peter Gmeiner. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Olaf Prante's work exemplifies the impact of innovation in the medical field. His patent and collaborations highlight his commitment to improving health outcomes through scientific research. His contributions continue to influence the landscape of medical science.